Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04974827
What this trial is testing

Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Hunan Cancer Hospital 46
Early research (Phase 1)Study completedNCT04616027
What this trial is testing

STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT

Who this might be right for
Diabetes Mellitus, Type 2Renal ImpairmentHealthy
Pfizer 42
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04752826
What this trial is testing

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Who this might be right for
Advanced MalignanciesOvarian CancerT-cell Lymphoma+1 more
BioInvent International AB 250
Testing effectiveness (Phase 2)WithdrawnNCT01907308
What this trial is testing

Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
University of Colorado, Denver
Large-scale testing (Phase 3)Study completedNCT02490488
What this trial is testing

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
AB Science 248
Not applicableUnknownNCT05043662
What this trial is testing

UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.

Who this might be right for
Urothelial CarcinomaDiagnoses DiseaseUreter Cancer+2 more
Changhai Hospital 110
Testing effectiveness (Phase 2)Looking for participantsNCT05817903
What this trial is testing

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Consorzio Oncotech 118
Testing effectiveness (Phase 2)Study completedNCT02951767
What this trial is testing

Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 119
Testing effectiveness (Phase 2)Study completedNCT01282463
What this trial is testing

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

Who this might be right for
Carcinoma of Urinary TractUrethral CarcinomaCarcinoma of Ureter+1 more
Eli Lilly and Company 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506
What this trial is testing

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerHER-2 Protein Overexpression
Fudan University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06884345
What this trial is testing

METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anhui Provincial Cancer Hospital 28
Early research (Phase 1)Study completedNCT03097016
What this trial is testing

Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Celgene 48
Testing effectiveness (Phase 2)Study completedNCT01843387
What this trial is testing

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyType 2 Diabetes
Mesoblast, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01091428
What this trial is testing

Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPeritoneal Cancer+1 more
Millennium Pharmaceuticals, Inc. 191
Testing effectiveness (Phase 2)Study completedNCT03326193
What this trial is testing

Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 105
Early research (Phase 1)Active Not RecruitingNCT06734234
What this trial is testing

Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Kidney Disease
GlaxoSmithKline 86
Early research (Phase 1)Study completedNCT02833857
What this trial is testing

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 11
Not applicableLooking for participantsNCT04291612
What this trial is testing

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Who this might be right for
Endometrial CancerEndometrioid AdenocarcinomaEndometrial Cancer Stage I
Memorial Sloan Kettering Cancer Center 1,715
Early research (Phase 1)Study completedNCT01122667
What this trial is testing

Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 24
Next Page